PMO November 2013

Page 1

A Peer-Reviewed Journal

November 2013 • Volume 2 • Number 7

BIOMARKERS • IMMUNOTHERAPY • TARGETED THERAPIES • DIAGNOSTICS

PM O

The official publication of

Global biomarkers Consortium Clinical Approaches

TM

to Targeted Technologies

TM

Personalized Medicine in Oncology TM

SPECIAL REPORT Second Annual Global Biomarkers Consortium Conference Highlights…...............................Page 366

INTERVIEW WITH THE INNOVATORS Multiple Myeloma and the MMRF CoMMpass Study: Revolutionizing Clinical Trial Data Dissemination: A Panel Discussion With the Researchers..................................................Page 380

HIGHLIGHTS FROM EHA 2013 CME Faculty Perspectives. Advances in the Treatment of Chronic Myeloid Leukemia.......................Page 388

MULTIPLE MYELOMA CME Considerations in Multiple Myeloma. Ask the Experts: The Role of Transplantation ...........Page 396

NSCLC CASE STUDY Personalizing Therapy in the Management of Recurrent Non–Small Cell Lung Cancer: Case Study of a Patient With an EGFR Mutation….....................................................Page 410

THE LAST WORD To PARP or Not to PARP – What Is the Question? Part 2.............................................................Page 413

www.PersonalizedMedOnc.com © 2013 Green Hill Healthcare Communications, LLC

In partnership with


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.